Figure 4
Figure 4. Effects of dmPGE2 or an EP4 agonist on the regulation of β-catenin. (A) Immunoblot analysis of GSK-3β phosphorylation (Ser9) in Lin–c-Kit+ cells (left panel). Densitometry analysis of the immunoblot is shown in the right panel. Representative data from 2 independent experiments are shown. (B) Immunoblot analysis of GSK-3β phosphorylation (Ser9) in Lin–c-Kit+ cells (left panel). Densitometry analysis of the immunoblot is shown in the right panel. (C) Immunoblot analysis of β-catenin phosphorylation (Ser675) in Lin–c-Kit+ cells (left panel). Densitometry analysis of the immunoblot is shown in the right panel. Representative data from 3 independent experiments are shown.

Effects of dmPGE2 or an EP4 agonist on the regulation of β-catenin. (A) Immunoblot analysis of GSK-3β phosphorylation (Ser9) in Linc-Kit+ cells (left panel). Densitometry analysis of the immunoblot is shown in the right panel. Representative data from 2 independent experiments are shown. (B) Immunoblot analysis of GSK-3β phosphorylation (Ser9) in Linc-Kit+ cells (left panel). Densitometry analysis of the immunoblot is shown in the right panel. (C) Immunoblot analysis of β-catenin phosphorylation (Ser675) in Linc-Kit+ cells (left panel). Densitometry analysis of the immunoblot is shown in the right panel. Representative data from 3 independent experiments are shown.

Close Modal

or Create an Account

Close Modal
Close Modal